Inventor · disambiguated record
Inja Waldhauer
Also filed as: WALDHAUER INJA
11 granted patents·8 pending applications·67 citations·filing 2010–2024
88Inventor score
Top patents by PatentIndex Score
19 records- 0195US11780920B2Antibodies binding to CD3 and CD19HOFFMANN LA ROCHE·Filed 2021·Granted Oct 10, 2023·4 cites·59 claims
- 0293US11591397B2Bispecific antibody molecules binding to CD3 and EGFRvIIIHOFFMANN LA ROCHE·Filed 2021·Granted Feb 28, 2023·2 cites·15 claims
- 0392US12215155B2Antibodies binding to CD3 and CD19HOFFMANN LA ROCHE·Filed 2023·Granted Feb 4, 2025·1 cites·64 claims
- 0491US12023368B2ImmunoconjugatesHOFFMANN LA ROCHE·Filed 2022·Granted Jul 2, 2024·1 cites·20 claims
- 0590US11214622B2Antibodies specific for DR5 and methods of useROCHE GLYCART AG·Filed 2018·Granted Jan 4, 2022·6 cites·13 claims
- 0690US9926379B2Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5ROCHE GLYCART AG·Filed 2014·Granted Mar 27, 2018·17 cites·28 claims
- 0788US11413331B2ImmunoconjugatesHOFFMANN LA ROCHE·Filed 2018·Granted Aug 16, 2022·4 cites·30 claims
- 0887US9481730B2DR5—FAP bispecific death receptor agonistic antibodiesBRUENKER PETER·Filed 2010·Granted Nov 1, 2016·29 cites·9 claims
- 0986US11672858B2Bispecific antibody molecules binding to CD3 and TYRP-1HOFFMANN LA ROCHE·Filed 2019·Granted Jun 13, 2023·2 cites·16 claims
- 1084US12473373B2Bispecific antibody molecules binding to CD3 and EGFRvIIIHOFFMANN LA ROCHE·Filed 2023·Granted Nov 18, 2025·0 cites·30 claims
- 1184US11827711B2Antibodies binding to NKG2DHOFFMANN LA ROCHE·Filed 2020·Granted Nov 28, 2023·1 cites·27 claims
- 1281US2025277035A1ANTIBODIES BINDING TO CD3 and CD19HOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1380US2023277662A1Antibodies binding to cd3HOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1476US2025073308A1ImmunoconjugatesHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1575US2024067734A1Antibodies binding to NKG2DHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1667US2025092136A1Antibodies binding to cd3HOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1766US2023071733A1ImmunoconjugatesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1859US2024376171A1Protease-activated polypeptidesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1957US2018326011A1ImmunoconjugatesHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Inja Waldhauer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →